| Line 480: | Line 480: | ||
* Goniewicz ML. Addict Neurosci. 2023 Jun;6:100077. doi: 10.1016/j.addicn.2023.100077. Epub 2023 Feb 26. PMID: 3708924 | * Goniewicz ML. Addict Neurosci. 2023 Jun;6:100077. doi: 10.1016/j.addicn.2023.100077. Epub 2023 Feb 26. PMID: 3708924 | ||
===2021: Screening of different cytotoxicity methods for the assessment of ENDS toxicity relative to tobacco cigarettes=== | ===2021: [https://www.sciencedirect.com/science/article/abs/pii/S0273230021001598 Screening of different cytotoxicity methods for the assessment of ENDS toxicity relative to tobacco cigarettes]=== | ||
*All tests showed reduced cell viability following 1R6F smoke exposure and slight or no reduction with ENDS at 24 hours. | *All tests showed reduced cell viability following 1R6F smoke exposure and slight or no reduction with ENDS at 24 hours. | ||
* | *[https://sci-hub.ru/10.1016/j.yrtph.2021.105018 PDF] | ||
*Citation: | *Citation: Caruso M, Emma R, Rust S, Distefano A, Carota G, Pulvirenti R, Polosa R, Li Volti G. Screening of different cytotoxicity methods for the assessment of ENDS toxicity relative to tobacco cigarettes. Regul Toxicol Pharmacol. 2021 Oct;125:105018. doi: 10.1016/j.yrtph.2021.105018. Epub 2021 Jul 24. PMID: 34314750. | ||
===2020: Association of electronic cigarette use with lead, cadmium, barium, and antimony body burden: NHANES 2015-2016=== | ===2020: Association of electronic cigarette use with lead, cadmium, barium, and antimony body burden: NHANES 2015-2016=== | ||
edits